Related Experiment Video
Updated: Apr 11, 2026

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
Osteoprotegerin in breast cancer: beyond bone remodeling
Michael Weichhaus1, Stephanie Tsang Mui Chung2, Linda Connelly3
1Division of Natural Science and Mathematics, Chaminade University of Honolulu, 3140 Waialae Avenue, Honolulu, HI, 96816, USA. michael.weichhaus@chaminade.edu.
Abstract:
Osteoprotegerin (OPG) is a secreted protein and member of the Tumor Necrosis Factor (TNF) Receptor superfamily. OPG has been well characterized as a regulator of bone metabolism which acts by blocking osteoclast maturation and preventing bone breakdown. Given this role, early studies on OPG in breast cancer focused on the administration of OPG in order to prevent the osteolysis observed with bone metastases. However OPG is also produced by the breast tumor cells themselves. Research focusing on OPG produced by breast tumor cells has revealed actions of OPG which promote tumor progression. In vitro studies into the role of OPG produced by breast tumor cells have demonstrated that OPG can block TNF-related apoptosis inducing ligand (TRAIL)-mediated apoptosis. Furthermore, in vivo studies show that OPG expression by breast tumors can promote tumor growth and metastasis. In addition it has been shown that OPG stimulates endothelial cell survival and tube formation thus it may indirectly promote breast tumor progression through impacting angiogenesis. This article will present a summary of the data concerning the tumor-promoting effects of OPG in breast cancer.
Insights
Osteoprotegerin (OPG) produced by breast tumors promotes cancer progression by blocking apoptosis and enhancing tumor growth and metastasis. OPG also supports angiogenesis, further contributing to breast cancer advancement.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteoprotegerin (OPG) is a TNF Receptor superfamily member regulating bone metabolism by inhibiting osteoclast activity.
- Early breast cancer research focused on exogenous OPG to prevent bone metastases-induced osteolysis.
- Tumor-derived OPG exhibits distinct functions promoting breast cancer progression.
Purpose of the Study:
- To summarize the tumor-promoting effects of osteoprotegerin (OPG) produced by breast cancer cells.
- To review evidence for OPG's role in tumor growth, metastasis, and angiogenesis.
Main Methods:
- Review of in vitro studies on OPG's effect on TRAIL-mediated apoptosis in breast cancer cells.
- Analysis of in vivo studies investigating OPG expression in breast tumors and its impact on tumor progression.
- Examination of OPG's influence on endothelial cell survival and tube formation.
Main Results:
- Breast tumor-expressed OPG inhibits TNF-related apoptosis inducing ligand (TRAIL)-mediated apoptosis.
- In vivo studies demonstrate that OPG promotes tumor growth and metastasis in breast cancer models.
- OPG enhances angiogenesis by promoting endothelial cell survival and tube formation.
Conclusions:
- Osteoprotegerin produced by breast tumors acts as a tumor promoter.
- OPG contributes to breast cancer progression through anti-apoptotic, pro-growth, pro-metastatic, and pro-angiogenic mechanisms.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling and Repair
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...

